FDA
-
-
-
-
-
-
-
IceCure adds Legacy Health in Portland to breast cancer cryoablation study
-
-
-
-
-
-
-
IceCure Medical enrolls first patient site for breast cancer study
-
-
-
-
-
-
-
IceCure Highlights Expanding Commercial Adoption of ProSense™ Cryoablation in Brazil Following FDA Clearance for Breast Cancer
-
-
-
-
-
-
-
IceCure's ProSense® Reports Nearly 90% Recurrence-Free Rate for Cryoablation of Kidney Cancer: Data Presented at ECIO 2026 and First-Ever Breast Cryoablation Master Class Overbooked
-
-
-
-
-
-
-
IceCure Reports 2025 Full Year Financial & Operational Results
-
-
-
-
-
-
-
Shero Imaging becomes first Missouri clinic to offer breast cryoablation
-
-
-
-
-
-
-
IceCure Expected to Report Record Fourth Quarter Sales in North America Driven by Recent FDA Clearance of ProSense® Cryoablation for Low-Risk Breast Cancer
-
335,761 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All


